Last Modified: February 3, 2002
(31st January 2003, European Society of Medical Oncology) Milan based, European School of Oncology (ESO) has announced a global initiative to honour accurate and informative cancer journalism. By launching the (Awarding Cancer Enlightenment) ACE Reporter Award, ESO urges journalists across the world to convey a clear interpretation of cancer facts, providing both the medical community and the public with information they can rely upon...more
You will need Adobe Acrobat Reader which is available free online, in order to view these PDF files.
Sep 2, 2014 - On June 24, the United Kingdom's National Institute of Health and Clinical Excellence (NICE) will publish guidance recommending use of the drug lenalidomide for life-extending therapy for multiple myeloma patients who have received two or more previous therapies, according to an early report in the June 18 online edition of the The Lancet Oncology.